Characteristics | No. (n=126) | Hazard ratio | 95% CI | P value | |
---|---|---|---|---|---|
Gender | |||||
Male | 84 | ||||
Female | 42 | 1.14 | 0.61–2.13 | 0.685 | |
Disease | |||||
Primary tumor only | 65 | ||||
Local recurrence | 33 | 2.28 | 1.03–5.05 | 0.042 | |
Synchronous Metastasis | 28 | 3.91 | 1.89–8.09 | 0.0002 | |
Treatment mode | |||||
RT | 53 | ||||
CRT | 73 | 0.97 | 0.52–1.81 | 0.92 | |
Grade 3 toxicity | |||||
No | 82 | ||||
Yes | 44 | 1.48 | 0.73–3.02 | 0.281 | |
Continuous variables | |||||
Age | 126 | 1.13 | 1.07–1.20 | 0.00002 | |
KPS Score | 126 | 0.99 | 0.95–1.02 | 0.558 | |
ECOG Score | 126 | 1.42 | 0.93–2.17 | 0.103 | |
Charlson Score | 126 | 1.21 | 1.09–1.36 | 0.001 |